Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers

Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers.

smoking mothers are thinner and their babies are thinner too, but even accepting the limitations of correction for this effect, the growth-retarding effect of smoking on the fetus is hardly affected by this correction. A similar conclusion was derived from Cardiff Birth Survey data, in a community study on smoking and pregnancy.8 We postulate from our data and from other data already reported, ...

Ipratropium bromide bronchodilator solution.

Effects of Inhaled Albuterol and Ipratropium Bromide

Study objective: Systemic administration of P-agonist and anticholinergic drugs markedly impair normal autonomic heart rate control. The purpose of this study was to quantify and compare the effects of therapeutic doses of inhaled albuterol and ipratropium on autonomic control of the cardiovascular system. Design: Randomized, double-blind, placebo-controlled, crossover design study. Setting: Te...

Ipratropium bromide and airways function in wheezy infants.

The airway response to nebulised ipratropium bromide was studied in 17 chronically or recurrently wheezy infants aged 4-15 months. The peripheral airway response was assessed by the change in maximum flow at functional residual capacity (Vmax FRC) and the upper and central airway response by the change in specific airways resistance. The significant reduction in specific airways resistance afte...

Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors.

BACKGROUND There are limited data assessing bronchodilator responsiveness (BDR) in infants and toddlers with recurrent wheezing, and factors associated with a positive response. OBJECTIVES In a multicenter study of children ≤ 36 months old, we assessed the prevalence of and factors associated with BDR among infants/toddlers with recurrent episodes of wheezing. METHODS Forced expiratory flow...